Literature DB >> 6198715

Leu 7+ (HNK-1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood.

A Porwit-Ksiazek, T Ksiazek, P Biberfeld.   

Abstract

In the present immunohistochemical studies, Leu 7+ (HNK-1+, human natural killer and killer) cells were found to occupy preferentially germinal centres of follicles in lymph nodes and tonsils. Leu 7+ cells were also present in germinal-like zones of spleen follicles and in mantle zones of hyperplastic thymus follicles and varied in localization in lymph nodes involved in different types of follicular centre cell-derived malignant lymphomas. Most of the Leu 7+ cells in the follicles expressed the Leu 3 (helper/inducer) marker. Double staining studies of tonsil sheep erythrocyte-rosetting and peripheral blood mononuclear cell suspensions showed that two main, mutually complementary, subpopulations of Leu 7+ cells could be distinguished in both cases, namely Leu 7+/Leu 4+ (subdivided into Leu 2+ (suppressor/cytotoxic) and Leu 3+) and Leu 7+/Leu 4-, including mostly cells with OKM 1 (myelomonocytic) characteristics. Thus, in the tonsil cell suspension the cells with Leu 7+ Leu 3+/OKM 1- immunophenotype strongly predominated, whereas among peripheral blood mononuclear cells Leu 7+Leu 2+/OKM 1- and Leu 7+/OKM 1+ immunophenotypes were mostly observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198715     DOI: 10.1111/j.1365-3083.1983.tb00882.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

Review 1.  T cells that promote B-Cell maturation in systemic autoimmunity.

Authors:  Jason S Weinstein; Sairy G Hernandez; Joe Craft
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

2.  Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses.

Authors:  Hyung W Lim; Peter Hillsamer; Chang H Kim
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Isolation and characterization of Leu 7+ germinal-center cells with the T helper-cell phenotype and granular lymphocyte morphology.

Authors:  A Velardi; A B Tilden; R Millo; C E Grossi
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

4.  Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype.

Authors:  G C Manara; G De Panfilis; C Ferrari; A Bonati; G Rocchi; R Scandroglio
Journal:  Histochemistry       Date:  1985

Review 5.  Pathophysiology of T follicular helper cells in humans and mice.

Authors:  Hideki Ueno; Jacques Banchereau; Carola G Vinuesa
Journal:  Nat Immunol       Date:  2015-02       Impact factor: 25.606

Review 6.  Malignant B-cells have receptors for and respond to interleukin-2.

Authors:  P Panayotides; R Lenkei; A Porwit; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

7.  Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A).

Authors:  J Shetye; J E Frödin; B Christensson; C Grant; B Jacobsson; S Sundelius; M Sylvén; P Biberfeld; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Quantitative and functional analysis of a human lymphocyte subset with the T-helper (Leu 3/T 4+) phenotype and natural killer (NK)-cell characteristics in patients with malignancy.

Authors:  A Velardi; L T Clement; C E Grossi
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

9.  HNK-1+ cells in non-Hodgkin's lymphoma: lack of relation with transferrin receptor expression on malignant cells.

Authors:  H J Schuurman; P M Kluin; G C de Gast; L Kater
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination.

Authors:  Jong R Kim; Hyung W Lim; Seung G Kang; Peter Hillsamer; Chang H Kim
Journal:  BMC Immunol       Date:  2005-02-04       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.